Myocardial Activity at 18 F-FAPI PET/CT and Risk for Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Li Wang,Yilu Wang,Juan Wang,Minghu Xiao,Xiao-Ying Xi,Bi-Xi Chen,Yao Su,Yu Zhang,Boqia Xie,Zhixiang Dong,Shihua Zhao,Min-Fu Yang
DOI: https://doi.org/10.1148/radiol.221052
IF: 19.7
2022-10-12
Radiology
Abstract:Background Myocardial fibrosis contributes to adverse cardiovascular events in hypertrophic cardiomyopathy (HCM). Purpose To explore the characteristics of cardiac fibroblast activation protein inhibitor (FAPI) PET/CT imaging and its relationship with the risk of sudden cardiac death (SCD) in HCM. Materials and Methods In this prospective study from July 2021 to January 2022, participants with HCM and healthy control participants underwent cardiac fluorine 18 (^(18)F)-labeled FAPI PET/CT...
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?